Target (CBDY) Shares Outstanding (Diluted Average) (2018 - 2023)
Target (CBDY) reported Shares Outstanding (Diluted Average) of $456.4 million for Q1 2023, down 26.03% year-over-year from $617.0 million in Q1 2022, and little changed quarter-over-quarter from $454.6 million in Q4 2022.
Target (CBDY) Shares Outstanding (Diluted Average) (2018 - 2023) Analysis & Trends
Target (CBDY) has 5 years of Shares Outstanding (Diluted Average) data on file, last reported at $456.4 million in Q1 2023.
- Shares Outstanding (Diluted Average) for Q1 2023 came in at $456.4 million, down 26.03% year-over-year; the trailing twelve-month figure through Mar 2023 was $456.4 million (down 26.03% YoY), and the FY2022 annual result was $454.6 million, down 3.76% from the prior year.
- Shares Outstanding (Diluted Average) steadied at $456.4 million in Q1 2023 per CBDY's latest filing, from $454.6 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $617.0 million in Q1 2022 and troughed at $121.2 million in Q1 2019.
- A 4-year average of $473.8 million and a median of $473.1 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2019 and 2023: Shares Outstanding (Diluted Average) soared 97.17% in 2019, then declined 26.03% in 2023.
- A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $121.2 million in 2019, then soared by 289.83% to $472.3 million in 2021, then declined by 3.76% to $454.6 million in 2022, then increased by 0.41% to $456.4 million in 2023.
- Business Quant data shows CBDY's Shares Outstanding (Diluted Average) at $456.4 million in Q1 2023, $454.6 million in Q4 2022, and $473.1 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Target | - | - | 191,787.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 456.41 Mn |
| Dec 31, 2022 | 454.56 Mn |
| Sep 30, 2022 | 473.10 Mn |
| Jun 30, 2022 | 606.47 Mn |
| Mar 31, 2022 | 617.03 Mn |
| Dec 31, 2021 | 472.31 Mn |
| Sep 30, 2021 | 489.89 Mn |
| Jun 30, 2021 | 573.37 Mn |
| Mar 31, 2019 | 121.16 Mn |
| Mar 31, 2018 | 61.45 Mn |